FDA Approves Drug That Doubles Pancreatic Cancer Survival

A newly approved pill nearly doubles survival time for patients with advanced pancreatic cancer, offering real hope for one of the deadliest cancer types.

The breakthrough targets a protein that drives tumor growth in 95% of pancreatic cancer cases.